Allucent Appoints Sugato De as Vice President of Regulatory Strategy and Head of Medical Technology
DECEMBER 12, 2022 Newly created role will expand support for growing number of complex clinical development programs involving medical devices, combination products and diagnostics CARY, N.C., December 12, 2022 – Global biopharmaceutical services leader, Allucent, announced today the appointment of Sugato De, M.S., as vice president of regulatory strategy and head of medical technology. In this […]
Allucent Expands Presence in India and Deepens World-Class Operational Functions with Opening of New Office in Chennai
OCTOBER 18, 2022 Global biopharmaceutical services leader, Allucent, today announced that it is continuing to grow its presence and cultivate its talent and capabilities in India with the opening of its second office in the country. The new 15,675 square-foot office, located in Chennai, will add approximately 35 jobs to start, and is part of the […]
Allucent Chairman and CEO Mark A. Goldberg Honored by PharmaVoice as One of the Year’s 100 Most Inspiring People in Life Sciences
SEPTEMBER 6, 2022 Global biopharmaceutical services leader, Allucent, announced today that its Chairman and CEO, Mark A. Goldberg, M.D., has been named to the PharmaVoice 100 ‘Legacy Leaders’ category, recognizing him as one of the 100 most inspiring people in the life sciences industry for 2022. Since 2005, PharmaVoice 100 has honored more than 1,700 […]
Allucent Appoints Steffany Cox as Chief Marketing Officer
AUGUST 22, 2022 Global biopharmaceutical services leader, Allucent, announced today the appointment of Steffany Cox as its chief marketing officer (CMO). In this C-Suite position, Cox will manage the company’s overall marketing strategy, help navigate market opportunities related to the company’s revenue, relationships, and reputation, and ensure the company’s mission and vision are reflected across […]
Allucent Appoints President of Clinical Pharmacology, Modeling and Simulation
JUNE 14, 2022 Allucent Appoints Katy Moore as President of Growing Clinical Pharmacology, Modeling and Simulation Division CARY, N.C., June, 14 2022– Global biopharmaceutical services leader, Allucent, announced today the appointment of Katy Moore, PharmD, RPh, as president of Clinical Pharmacology, Modeling and Simulation (CPMS). In this critical role, Moore will lead an expert team of pharmacometricians building […]
CATO SMS is Now Allucent
MAY 2, 2022 New Name and Branding Reflect Company’s Mission to Help Bring Next-Generation Therapies to Light News Summary CARY, N.C., May 2, 2022 – Global biopharmaceutical services leader, CATO SMS, today unveiled its new name, Allucent, with bold branding to emphasize the company’s spotlight on serving the specialized needs of small and mid-sized biotech companies. This […]
CATO SMS AND PHARM-OLAM MERGE TO CREATE GLOBAL BIOPHARMACEUTICAL SERVICES LEADER
CATO SMS and Pharm-Olam are merging to form a global biopharmaceutical services organization to serve small and mid-sized companies developing therapies. JANUARY 5, 2022 Newly Combined Company Uniquely Positioned to Serve Small and Mid-Sized Biopharmaceutical Companies News Summary CARY, N.C. and Bracknell, U.K., January 5, 2022 – Research Triangle Park, N.C.-based CATO SMS and Bracknell, […]
CATO SMS and Pharm-Olam Merge to Create Global Biopharmaceutical Services Leader
JANUARY 5, 2022 Newly Combined Company Uniquely Positioned to Serve Small and Mid-Sized Biopharmaceutical Companies News Summary CARY, N.C. and Bracknell, U.K., January 5, 2022 – Research Triangle Park, N.C.-based CATO SMSand Bracknell, U.K.-headquarteredPharm-Olam, both providers of specialized clinical research services, announced today that they are merging to form a leading global biopharmaceutical services organization uniquely positioned […]